Jeff Fairman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jeff fairman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jeff Fairman Today - Breaking & Trending Today

Jeff Fairman Sells 4,112 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) Stock

Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) VP Jeff Fairman sold 4,112 shares of Vaxcyte stock in a transaction on Friday, May 20th. The stock was sold at an average price of $25.50, for a total transaction of $104,856.00. Following the transaction, the vice president now directly owns 321,227 shares in the company, valued at $8,191,288.50. […] ....

Jeff Fairman , Zacks Investment Research , Blackrock Inc , Vanguard Group Inc , Needham Company , Frazier Life Sciences Management , Vaxcyte Company Profile Get Rating , Vaxcyte Inc , Get Rating , State Street Corp , Street Corp , Investment Research , Company Profile , Nasdaq Pcvx , Insider Trading , Nsider Trades ,

Insider Selling: Vaxcyte, Inc. (NASDAQ:PCVX) VP Sells 5,000 Shares of Stock

Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) VP Jeff Fairman sold 5,000 shares of the business’s stock in a transaction on Tuesday, April 5th. The shares were sold at an average price of $25.59, for a total value of $127,950.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is […] ....

United States , Jeff Fairman , Groupa Strep , Morgan Stanley , Securities Exchange Commission , Zacks Investment Research , America Corp , Parametric Portfolio Associates , Invesco Ltd , Needham Company , Vaxcyte Company Profile Get Rating , Vaxcyte Inc , Royal Bank , Get Rating , Exchange Commission , Investment Research , Company Profile , Nasdaq Pcvx , Insider Trading , Nsider Trades ,

Vaxcyte (NASDAQ:PCVX) Shares Gap Up to $25.68

Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating)’s stock price gapped up before the market opened on Thursday . The stock had previously closed at $25.68, but opened at $26.55. Vaxcyte shares last traded at $26.38, with a volume of 1,109 shares traded. Several research firms have recently commented on PCVX. Zacks Investment Research downgraded shares of […] ....

Paul Sauer , Jeff Fairman , Groupa Strep , Zacks Investment Research , Ensign Peak Advisors Inc , Needham Company , Nisa Investment Advisors , Advisor Group Holdings Inc , Vaxcyte Inc , Royal Bank , Manchester Capital Management , Get Rating , Investment Research , Investment Advisors , Peak Advisors Inc , Capital Management , Group Holdings , Nasdaq Pcvx ,